Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,858
Total Claims
$714K
Drug Cost
774
Beneficiaries
$923
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 2,621 Pain Management providers
+53%
Opioid rate vs peers
63.0% vs 41.3% avg
+131%
Cost per patient vs peers
$923 vs $399 avg
+167%
Brand preference vs peers
10.0% vs 3.8% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
63.0%
Opioid Rate
5,583
Opioid Claims
$572K
Opioid Cost
25.8%
Long-Acting Rate
This provider's opioid prescribing rate of 63.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 887 claims · $451K
Generic: 7,971 claims · $263K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 218 | $178K |
| Oxycodone Myristate | 249 | $103K |
| Buprenorphine | 273 | $85K |
| Hydrocodone/Acetaminophen | 2,259 | $59K |
| Rimegepant Sulfate | 29 | $43K |
| Oxycodone Hcl | 105 | $39K |
| Oxycodone Hcl/Acetaminophen | 1,004 | $37K |
| Hydrocodone Bitartrate | 72 | $33K |
| Lidocaine | 115 | $15K |
| Gabapentin | 728 | $12K |
| Pregabalin | 417 | $11K |
| Buprenorphine Hcl | 275 | $10K |
| Oxycodone Hcl | 601 | $9,729 |
| Morphine Sulfate | 440 | $9,401 |
| Diclofenac Sodium | 111 | $9,265 |
Prescribing Profile
28
Unique Drugs
21.0
Anomaly Score
Patient Profile
64
Avg Age
66%
Female
1.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About